20,000 patients enrolled in pneumonia Fact-Finding mission
NCT ID NCT02139163
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is collecting information from 20,000 adults with community-acquired pneumonia to understand how common it is, what puts people at risk, and how it interacts with other health conditions. Researchers will ask about symptoms, treatments, and hospital stays. No new treatments are being tested.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help identify who is most at risk for pneumonia and improve prevention strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test any new drug or therapy, so it cannot lead to a cure or new treatment on its own.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 20,000 people
The number the study aims to enrol. It can still change while the study runs.
- Start date
-
Oct 2002
- Expected to finish
-
Jun 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
patients with pneumonia
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * age ≥ 18 * infiltrate on chest X-ray * further Inclusion criteria (at least one must apply): cough or purulent sputum or pathologic lung auscultation (crackles) or fever Exclusion Criteria: * Hospitalization lasting longer than 48 hours prior to the diagnosis of the current pneumonia * Newly diagnosed, active pulmonary tuberculosis within the last 2 months
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Community-acquired pneumonia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Medical School Hannover
RECRUITINGHanover, 30625, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test vs. clinical check: which safely cuts antibiotic use in pneumonia?
- Flu vaccine showdown: which shot protects seniors best?
- Can inhaled nitric oxide speed pneumonia recovery?
- Pneumonia culprit may be rarer than doctors think
- Shorter antibiotic course may be just as effective for kids with pneumonia
- Shocking muscles back to health: could zaps help seniors recover from lung illness?